June Sherie Almenoff - 12 Nov 2024 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
12 Nov 2024
Net transactions value
+$12,750
Form type
4
Filing time
14 Nov 2024, 17:21:55 UTC
Previous filing
05 Nov 2024
Next filing
12 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $6,250 +500 $12.50 500 12 Nov 2024 By Meadowlark Management, LLC F1, F2
transaction AVTX Common Stock Purchase $6,500 +500 +100% $13.00 1,000 13 Nov 2024 By Meadowlark Management, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.